nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—SLC5A1—Hexose uptake—NUP62—salivary gland cancer	0.0578	0.0578	CbGpPWpGaD
Canagliflozin—SLC5A2—Hexose uptake—NUP62—salivary gland cancer	0.0578	0.0578	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.0397	0.0397	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.0397	0.0397	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—PYGB—salivary gland cancer	0.0257	0.0257	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—PYGB—salivary gland cancer	0.0257	0.0257	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0202	0.0202	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0202	0.0202	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—ST3GAL4—salivary gland cancer	0.0201	0.0201	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—ST3GAL4—salivary gland cancer	0.0201	0.0201	CbGpPWpGaD
Canagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—salivary gland cancer	0.0198	0.0198	CbGpPWpGaD
Canagliflozin—UGT1A9—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0185	0.0185	CbGpPWpGaD
Canagliflozin—ABCC2—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.018	0.018	CbGpPWpGaD
Canagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—salivary gland cancer	0.0168	0.0168	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—NUP62—salivary gland cancer	0.0145	0.0145	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—NUP62—salivary gland cancer	0.0145	0.0145	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.0145	0.0145	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.0145	0.0145	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—VCAN—salivary gland cancer	0.0144	0.0144	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—VCAN—salivary gland cancer	0.0144	0.0144	CbGpPWpGaD
Canagliflozin—SLC5A1—Orphan transporters—CREBBP—salivary gland cancer	0.0117	0.0117	CbGpPWpGaD
Canagliflozin—SLC5A2—Orphan transporters—CREBBP—salivary gland cancer	0.0117	0.0117	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—GAS6—salivary gland cancer	0.00983	0.00983	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—GAS6—salivary gland cancer	0.00936	0.00936	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00926	0.00926	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00926	0.00926	CbGpPWpGaD
Canagliflozin—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00848	0.00848	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ISYNA1—salivary gland cancer	0.00803	0.00803	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ISYNA1—salivary gland cancer	0.00803	0.00803	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—WNT5B—salivary gland cancer	0.00753	0.00753	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—WNT5B—salivary gland cancer	0.00753	0.00753	CbGpPWpGaD
Canagliflozin—UGT1A9—PPAR Alpha Pathway—CCND1—salivary gland cancer	0.00748	0.00748	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00735	0.00735	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00735	0.00735	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL17RD—salivary gland cancer	0.00727	0.00727	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PYGB—salivary gland cancer	0.00727	0.00727	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CPSF4—salivary gland cancer	0.00727	0.00727	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CPSF4—salivary gland cancer	0.00727	0.00727	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL17RD—salivary gland cancer	0.00727	0.00727	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PYGB—salivary gland cancer	0.00727	0.00727	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MAML3—salivary gland cancer	0.00665	0.00665	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MAML3—salivary gland cancer	0.00665	0.00665	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—MARCKS—salivary gland cancer	0.00655	0.00655	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—MARCKS—salivary gland cancer	0.00655	0.00655	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ISYNA1—salivary gland cancer	0.0062	0.0062	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PYGB—salivary gland cancer	0.00609	0.00609	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PYGB—salivary gland cancer	0.00609	0.00609	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00594	0.00594	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—ST3GAL4—salivary gland cancer	0.0057	0.0057	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—ST3GAL4—salivary gland cancer	0.0057	0.0057	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00562	0.00562	CbGpPWpGaD
Canagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00522	0.00522	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—DTX4—salivary gland cancer	0.00518	0.00518	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—DTX4—salivary gland cancer	0.00518	0.00518	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MARCKS—salivary gland cancer	0.00506	0.00506	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PHGDH—salivary gland cancer	0.00496	0.00496	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PHGDH—salivary gland cancer	0.00496	0.00496	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ST3GAL4—salivary gland cancer	0.00478	0.00478	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ST3GAL4—salivary gland cancer	0.00478	0.00478	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PYGB—salivary gland cancer	0.0047	0.0047	CbGpPWpGaD
Canagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.0046	0.0046	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00436	0.00436	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—GAS6—salivary gland cancer	0.00436	0.00436	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AQP1—salivary gland cancer	0.00434	0.00434	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AQP1—salivary gland cancer	0.00434	0.00434	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—FGF16—salivary gland cancer	0.00428	0.00428	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—FGF16—salivary gland cancer	0.00428	0.00428	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NUP62—salivary gland cancer	0.00411	0.00411	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NUP62—salivary gland cancer	0.00411	0.00411	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—VCAN—salivary gland cancer	0.00408	0.00408	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—VCAN—salivary gland cancer	0.00408	0.00408	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PHGDH—salivary gland cancer	0.00383	0.00383	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MAML2—salivary gland cancer	0.00372	0.00372	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MAML2—salivary gland cancer	0.00372	0.00372	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ST3GAL4—salivary gland cancer	0.00369	0.00369	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—JMJD1C—salivary gland cancer	0.00349	0.00349	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NUP62—salivary gland cancer	0.00344	0.00344	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NUP62—salivary gland cancer	0.00344	0.00344	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—VCAN—salivary gland cancer	0.00341	0.00341	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—VCAN—salivary gland cancer	0.00341	0.00341	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AQP1—salivary gland cancer	0.00335	0.00335	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—CREBBP—salivary gland cancer	0.00319	0.00319	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—JAG1—salivary gland cancer	0.00318	0.00318	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—JAG1—salivary gland cancer	0.00318	0.00318	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—FGFR4—salivary gland cancer	0.00316	0.00316	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—FGFR4—salivary gland cancer	0.00316	0.00316	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.00312	0.00312	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—FBXW7—salivary gland cancer	0.00311	0.00311	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—FBXW7—salivary gland cancer	0.00311	0.00311	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00302	0.00302	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00285	0.00285	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00285	0.00285	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NUP62—salivary gland cancer	0.00266	0.00266	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00264	0.00264	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—VCAN—salivary gland cancer	0.00264	0.00264	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—FOXO3—salivary gland cancer	0.00263	0.00263	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—FOXO3—salivary gland cancer	0.00263	0.00263	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00258	0.00258	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ISYNA1—salivary gland cancer	0.0023	0.0023	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—GAS6—salivary gland cancer	0.00225	0.00225	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—GUCY1A3—salivary gland cancer	0.00225	0.00225	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.0022	0.0022	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—EP300—salivary gland cancer	0.00217	0.00217	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00216	0.00216	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.00215	0.00215	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MAP2K2—salivary gland cancer	0.00214	0.00214	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MAP2K2—salivary gland cancer	0.00214	0.00214	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.00212	0.00212	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00205	0.00205	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00201	0.00201	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MARCKS—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOTCH1—salivary gland cancer	0.00176	0.00176	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOTCH1—salivary gland cancer	0.00176	0.00176	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PYGB—salivary gland cancer	0.00174	0.00174	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00161	0.00161	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CREBBP—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CREBBP—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.00146	0.00146	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PHGDH—salivary gland cancer	0.00142	0.00142	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00139	0.00139	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ST3GAL4—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MYB—salivary gland cancer	0.00134	0.00134	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CREBBP—salivary gland cancer	0.00133	0.00133	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CREBBP—salivary gland cancer	0.00133	0.00133	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AQP1—salivary gland cancer	0.00124	0.00124	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TP53—salivary gland cancer	0.00122	0.00122	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ISYNA1—salivary gland cancer	0.0012	0.0012	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTEN—salivary gland cancer	0.00114	0.00114	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTEN—salivary gland cancer	0.00114	0.00114	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.0011	0.0011	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—EP300—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—EP300—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CREBBP—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NUP62—salivary gland cancer	0.000983	0.000983	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MARCKS—salivary gland cancer	0.00098	0.00098	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—VCAN—salivary gland cancer	0.000975	0.000975	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000963	0.000963	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTEN—salivary gland cancer	0.000953	0.000953	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTEN—salivary gland cancer	0.000953	0.000953	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00094	0.00094	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PYGB—salivary gland cancer	0.000911	0.000911	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—EP300—salivary gland cancer	0.000909	0.000909	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—EP300—salivary gland cancer	0.000909	0.000909	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000859	0.000859	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000856	0.000856	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PIK3CA—salivary gland cancer	0.000803	0.000803	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PIK3CA—salivary gland cancer	0.000803	0.000803	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000798	0.000798	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000794	0.000794	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PHGDH—salivary gland cancer	0.000743	0.000743	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—HRAS—salivary gland cancer	0.000742	0.000742	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—HRAS—salivary gland cancer	0.000742	0.000742	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTEN—salivary gland cancer	0.000736	0.000736	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ST3GAL4—salivary gland cancer	0.000715	0.000715	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—EP300—salivary gland cancer	0.000701	0.000701	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000696	0.000696	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3CA—salivary gland cancer	0.000672	0.000672	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3CA—salivary gland cancer	0.000672	0.000672	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000672	0.000672	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000651	0.000651	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AQP1—salivary gland cancer	0.000649	0.000649	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000649	0.000649	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00064	0.00064	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000626	0.000626	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000611	0.000611	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000583	0.000583	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000569	0.000569	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000529	0.000529	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3CA—salivary gland cancer	0.000519	0.000519	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NUP62—salivary gland cancer	0.000515	0.000515	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—VCAN—salivary gland cancer	0.000511	0.000511	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CREBBP—salivary gland cancer	0.000492	0.000492	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000492	0.000492	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000481	0.000481	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000474	0.000474	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000458	0.000458	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000451	0.000451	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000448	0.000448	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000447	0.000447	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000431	0.000431	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000426	0.000426	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000401	0.000401	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000386	0.000386	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CREBBP—salivary gland cancer	0.000381	0.000381	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000373	0.000373	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.00035	0.00035	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—EP300—salivary gland cancer	0.000335	0.000335	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00032	0.00032	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000305	0.000305	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000278	0.000278	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000276	0.000276	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTEN—salivary gland cancer	0.000272	0.000272	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—EP300—salivary gland cancer	0.00026	0.00026	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CA—salivary gland cancer	0.000248	0.000248	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—salivary gland cancer	0.00024	0.00024	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—HRAS—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000226	0.000226	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CREBBP—salivary gland cancer	0.0002	0.0002	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CA—salivary gland cancer	0.000192	0.000192	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.000175	0.000175	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTEN—salivary gland cancer	0.000143	0.000143	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—EP300—salivary gland cancer	0.000136	0.000136	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTEN—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—EP300—salivary gland cancer	0.000119	0.000119	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CREBBP—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CA—salivary gland cancer	0.000101	0.000101	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CA—salivary gland cancer	8.81e-05	8.81e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTEN—salivary gland cancer	7.69e-05	7.69e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—EP300—salivary gland cancer	7.34e-05	7.34e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	5.43e-05	5.43e-05	CbGpPWpGaD
